Navarixin (SCH 527123, MK-7123)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Navarixin (SCH 527123, MK-7123), covering 2014-11-17 to 2014-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Long-Term Study of the Effects of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe COPD (MK-7123-019) [Phase 2]